Objective: To assess the clinical impact of adverse reactions related to drugs for primary headache treatment.Methods: We examined the adverse reactions to 360 medications prescribed by the specialists of the Headache Centre of the University of Modena and Reggio Emilia to 256 consecutive outpatients (214 female, 42 male; mean age: 38.88+/-14.06 years; range 10-72 years). Adverse reactions were reported by patients during scheduled follow-up visits, classified by specialists and reassessed by a clinical pharmacologist.Results: Adverse reactions with a causal relationship classified as definite/probable/possible were 202 (56%): 62% (80/129) were due to acute treatments and 53% (122/231) to prophylactic treatments (chi(2) test, P=0.115 ns). More than 90% of the adverse reactions were of limited intensity [mild (58%) or moderate (36%)]. Only 5% were severe, and two reactions (1%) were serious. The most affected apparatus was the nervous system (41%). Of these adverse reactions, 43% caused the discontinuance of the treatment, especially of prophylaxis (54%). Patients evaluated 70% of the medications as effective, but, at the same time, they considered most of the adverse reactions (69%) unacceptable.Conclusion: Adverse reactions related to headache medications have a strong impact on patients' management, even if their real intensity and severity are usually very limited. Drugs for headache treatment are still far from being ideal drugs. To prevent the discontinuance of effective medications, the physician, prior to prescribing, should assess, together with the patient, the acceptability of the more common adverse drug reactions.
Adverse reactions related to drugs for headache treatment: clinical impact / Ferrari, Anna; Ottani, Alessandra; Bertolini, Alfio; A. F. G., Cicero; C. P. R., Coccia; S., Leone; Sternieri, Emilio. - In: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. - ISSN 0031-6970. - STAMPA. - 60(12)(2005), pp. 893-900. [10.1007/s00228-004-0864-7]
|Data di pubblicazione:||2005|
|Titolo:||Adverse reactions related to drugs for headache treatment: clinical impact|
|Autore/i:||Ferrari, Anna; Ottani, Alessandra; Bertolini, Alfio; A. F. G., Cicero; C. P. R., Coccia; S., Leone; Sternieri, Emilio|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1007/s00228-004-0864-7|
|Codice identificativo ISI:||WOS:000227368200010|
|Codice identificativo Scopus:||2-s2.0-15244340224|
|Codice identificativo Pubmed:||15657778|
|Citazione:||Adverse reactions related to drugs for headache treatment: clinical impact / Ferrari, Anna; Ottani, Alessandra; Bertolini, Alfio; A. F. G., Cicero; C. P. R., Coccia; S., Leone; Sternieri, Emilio. - In: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. - ISSN 0031-6970. - STAMPA. - 60(12)(2005), pp. 893-900. [10.1007/s00228-004-0864-7]|
|Tipologia||Articolo su rivista|
File in questo prodotto:
|Adverse reactions related to drugs for headache treatment.pdf||Lavoro completo||Post-print dell'autore (bozza post referaggio)||Administrator Richiedi una copia|
|Reazioni avverse ai farmaci 2005.pdf||riassunto in Italiano in www.farmacovigilanza.org||Altro materiale allegato||Open Access Visualizza/Apri|
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris